Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 30, 2023 (3 years ago)

V-FORCE Homeopathic

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

V-FORCE Homeopathic, 1 FL OZ (30 ml) per glass bottle, Distributed by: BioActive Nutritional, Inc., 1803 N. Wickham Rd., Melbourne, FL 32935

Recalling firm
Grato Holdings, Inc.
Origin
IA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0099-2024 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Grato Holdings, Inc.

All 2023 recalls
Class II · Moderate risk

Earache Drops

Microbial contamination of non-sterile product.

Terminated Microbial contamination Grato Holdings, Inc. NDC 0363-3233-15 D-0991-2022

Other cgmp deviation recalls from 2023

All cgmp deviation recalls
Class II · Moderate risk

Sertraline Tablets

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Ongoing cGMP deviation Legacy Pharmaceutical Packaging LLC NDC 68645-523-54 D-0205-2024
Class II · Moderate risk

Oxygen

cGMP Deviations

Terminated cGMP deviation Family Medical Supply Inc D-0106-2024
Class II · Moderate risk

Strong Iodine Solution U.S.P.

CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.

Terminated cGMP deviation Safecor Health, LLC NDC 48433-230-15 D-0082-2024
Class II · Moderate risk

Integrity Biochem HSC 70-VA

CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.

Terminated cGMP deviation Integrity Bio-Chemicals LLC D-0111-2024